NEWS & PRESS RELEASES
Milan, 2005 - breaking news

Acamprosate - a safe and effective drug to maintain abstinence in alcohol dependent patients.

Labochim is pleased to announce that thanks to its intensive R&D activity is now able to offer its clients a new product: Acamprosate. This drug, has proved its efficacy in treating alcohol dependent individuals seeking to continue to remain alcohol-free after they have stopped drinking.

Labochim completed the R&D phase and is ready to start industrial production. Information and samples are available on request.